Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiproton radiotherapy.

Niels Bassler1, Jan Alsner, Gerd Beyer

  • 1Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. n.bassler@dkfz.de

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|December 26, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 Study.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same author

Incidence and outcome of oropharynx carcinoma in Denmark 1986-2020: A population based DAHANCA study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial.

BMC cancer·2026
Same author

A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.

Cancer research communications·2026
Same author

Motion-based tissue <i>ex vivo</i> (MOTEX) assay to assess proton and X-ray irradiation responses in head and neck squamous cell carcinoma.

Clinical and translational radiation oncology·2026
Same author

Histological characterization and quantification of late damage in mice after proton and photon irradiation.

International journal of radiation biology·2026
Same journal

Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer - Endorsed by ASTRO.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Early ADC changes in risk-model-defined brain regions precede contrast-enhancing lesions after proton therapy for low-grade glioma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Tumor volume reduction during adaptive radiotherapy is a strong prognostic factor for oropharyngeal cancer: A retrospective multicenter study?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
See all related articles
This summary is machine-generated.

Antiprotons show promise for radiation therapy due to their unique annihilation properties, offering potential for enhanced biological effects and real-time monitoring. Further research is needed to optimize their clinical application.

Area of Science:

  • Medical Physics
  • Particle Physics
  • Radiation Oncology

Background:

  • Antiprotons offer unique physical and radiobiological properties for potential use in radiation therapy.
  • Antiproton annihilation at the Bragg peak releases significant energy, augmenting local dose and biological effect.
  • Secondary particles from annihilation, including high-LET pions, contribute to increased biological effectiveness.

Purpose of the Study:

  • To investigate the physical and radiobiological properties of antiprotons for radiation therapy applications.
  • To compare antiproton therapy with existing modalities like protons and carbon ions.
  • To develop and validate computational models for antiproton treatment planning.

Main Methods:

  • Dosimetry experiments using ionization chambers, alanine pellets, and radiochromic film at CERN.

Related Experiment Videos

  • Radiobiological studies with V79 Chinese hamster cells, comparing antiprotons with protons and carbon ions.
  • Evaluation and comparison of Monte Carlo particle transport codes against experimental data.

    • Main Results:

    • Antiproton dosimetry and radiobiology experiments were successfully conducted at CERN.
    • Monte Carlo simulations were validated against experimental data, enabling generation of treatment planning data.
    • Biological effects in the plateau region may be reduced by a factor of 4 compared to protons.

    Conclusions:

    • Antiprotons present a viable option for radiation therapy, with potential for enhanced biological effects and precise dose delivery.
    • Treatment planning software is being extended to incorporate antiproton beam capabilities.
    • Further studies are required to fully assess the clinical consequences and optimize antiproton therapy planning.